Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about Chong Kun Dang Pharm aggregated by PharmaCompass.com.

    Client Virtual Booth

    CHONG KUN DANG PHARM

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Chong Kun Dang Pharm
    korearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    8, Chungjeong-ro, Seodaemun-gu, Seoul
    Telephone
    Telephone
    +82-2-2194-0555
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.ckdpharm.com/home
    Linkedin
    Linkedin
    https://in.linkedin.com/company/chong-kun-dang-pharm.
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Aclipse Expands Drug Development Pipeline with Agreement with Chong Kun Dang
    Aclipse Expands Drug Development Pipeline with Agreement with Chong Kun Dang

    https://www.businesswire.com/news/home/20230914038839/en

    BUSINESSWIRE
    14 Sep 2023
    Share Share
    Chong Kun Dang Pharm Licenses Synaffix ADC Technology
    Chong Kun Dang Pharm Licenses Synaffix ADC Technology

    https://www.prnewswire.com/news-releases/chong-kun-dang-pharm-licenses-synaffix-adc-technology-adds-novel-adc-candidate-to-oncology-pipeline-301738575.html

    PR NEWSWIRE
    06 Feb 2023
    Share Share
    Chong Kun Dang to export anemia biosim Nesbell to Middle East
    Chong Kun Dang to export anemia biosim Nesbell to Middle East

    https://www.koreabiomed.com/news/articleView.html?idxno=11545#:~:text=Chong%20Kun%20Dang%20said%20it,an%20Oman%2Dbased%20pharmaceutical%20company.

    KOREABIOMED
    05 Jul 2021
    Share Share
    Chong Kun Dang proceeds to phase 2 trial in Russia to treat COVID-19
    Chong Kun Dang proceeds to phase 2 trial in Russia to treat COVID-19

    http://www.koreaherald.com/view.php?ud=20200901000612

    L. Jeong-yeo KOREAN HERALD
    01 Sep 2020
    Share Share
    OSE Immunotherapeutics inks licensing deal with Chong Kun Dang Pharma
    OSE Immunotherapeutics inks licensing deal with Chong Kun Dang Pharma

    https://www.biospectrumasia.com/news/25/14868/ose-immunotherapeutics-inks-licensing-deal-with-chong-kun-dang-pharma.html

    BIOSPECTRUM ASIA
    11 Nov 2019
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search